HomeAbout MBIMilestones


  Maxigen Biotech Inc, founded.
  Set up Yang Ming University business incubation center.
  Completed capital increase of NTD100 million.
  Established Wugu Biotech facility in new Taipei.
  Set up Tainan skincare facility.
  Established collagen, hyaluronic acid core process technology.
  Set up Biotech and Skincare business units.
  FormaGraft bone graft substitute received FDA clearance .
  Nuvasive a Nasdaq listed company became a strategic partner of MBI on ForgraGraft product.
  Foramic, bone graft substitute, ArtiAid, intra-articular injection and ViscAid, ophthalmic viscoelastic CE certificated.
  Biotech facility passed FDA site inspection on Oct. 2009.
  Tainan skincare facility received GMP certificate on March 2009 and ISO 9001.
  Completed NTD 130 million capital increase.
  GingivAid collagen dental bone graft  and FormaAid collagen membrane received TFDA product certificate.
  SurgiAid wound dress received FDA clearance.
  Received NTD 50 million fund from Ministry of Economic Affairs to develop bone cement product.
  Went IPO.
  Went IPO.
  Acquired Hua Ya Science park land to build a new plant.
  Set up BIOFLASH skincare counter at Taipei 101.
  Won the 2011 Watson Health and Beauty "Best Product" and "Best New Product" awards.
  BIOFLASH "Heart Travel" masks launched at OK convenient store and Cosmed chain stores.
  DR NEO classic launched at Watsons chain stores.
  Started a technical cooperation with Exactech, a listed company on Nasdaq.
  Gound breaking at Hua Ya Science Park.
  MBI went public.
  Biotech facility passed the 2nd site audit and inspection by FDA.
  Hua Ya HQ operational.